Skip to main content
Equibles

ICCM · IceCure Medical Ltd.

Track ICCM — free

Use ICCM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ICCM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.54 -0.03 (-1.91%) At close · Oct 5
Rebalance outlook locked
Market Cap
$8.02M
Shares
4.64M
Volume · Oct 5 159.27K Avg daily vol (3M) 152.31K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.54 Open$1.59 Day$1.47–1.61 52W close$1.54–30.00 Avg vol 30d138K Short int103K · 2.2% float · 1.0d Short vol46% Last earningsAug 12, 2026 DataAug 2021–Oct 2026

Up next

Next earnings call
Nov 4, 2026 Est · unconfirmed · in 4 wks
Q2 2026 earnings call transcript
call held Aug 12, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+2.7%
Year over year
Operating margin
-446.7%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+25.0%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
2.2%
Latest settlement · 1.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 15.5 · calm Equity put/call 0.59
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −84%
below
Price vs 50-day avg −35%
below
RSI (14) 24
oversold
MACD trend Positive
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −31%
trailing
6-month return −86%
trailing
YTD return −92%
this year
Relative strength −97%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $2 › 200d $10 — 200d above 50d
Institutional flow Distributing
-39% holders QoQ · +2 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
2.21% of float · ▼ -4.7% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
11 holders — near 3-yr low, contrarian setup
Squeeze score 40
elevated · 0–100
Fundamentals
Weak
Revenue growth +3%
Y/Y
Gross margin 36%
contracting
EPS growth −20%
Y/Y
Free cash flow $-14.6M
Quant / Vol
risk profile
Very High
Volatility 230%
annualized · 1-yr
Max drawdown −95%
past year
ATR 12.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−84% Bearish
Price vs 50-day avg
−35% Bearish
RSI (14)
24 Neutral
MACD trend
Positive Bullish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $2 › 200d $10 — 200d above 50d
Institutional flow Distributing
-39% holders QoQ · +2 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
2.21% of float · ▼ -4.7% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
11 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $2 Now $2 · 0% Range high $30
vs 200-day avg -84% vs 50-day avg -35%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ICCM
IceCure Medical Ltd.
this stock
$8.02M — +2.7% — 2.2%
ABT
Abbott Laboratories
 $174.90B -20.1% +5.7% 28.1 1.1%
MDT
Medtronic plc
 $113.38B -8.4% +8.4% 21.8 1.3%
SYK
Stryker Corp
 $104.47B -18.8% +11.2% 28.2 2.0%
BSX
Boston Scientific Corp
 $63.59B -55.5% +12.5% 17.8 3.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
11
% held
2.8%
Net QoQ
+23.0K sh
Top holder
JANE STREET GROUP, LLC
Held Float
View
Short & Settlement
Short Interest Falling
Shares short
102.6K
Days to cover
1.0d
Change
-5.1K sh
View
Short Volume
Short vol %
46%
As of
Oct 5, 2026
Short Total
View
Fails to Deliver
FTD shares
51
Value
$113
As of
Sep 14, 2026
View
Off-Exchange
Off-exchange %
47.2%
Week of
Aug 31, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$3.4M
Net income (FY)
$-15.1M
EPS diluted
$7.20
View
Filings
SEC Filings
Latest
6-K
Filed
Oct 5, 2026
This year
36
View
Exempt Offerings
Offering
$16.5M
Filed
Jun 25, 2026
View
Earnings & Events
Webcasts Upcoming
Next webcast
Nov 2, 2026
Last webcast
Aug 12, 2026
View
Investor Relations
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
ICCM -5.5% -30.9% -85.5% -4.6% -91.6%
SPY +1.2% +0.6% +11.6% +1.6% +13.6%
vs SPY -6.7% -31.5% -97.1% -6.2% -105.2%
Key facts CIK 1584371 CUSIP M53071201 Visit website Investor relations